We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+19.9%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$14.1B
AUM Growth
+$2.31B
Cap. Flow
+$376M
Cap. Flow %
2.66%
Top 10 Hldgs %
9.76%
Holding
488
New
31
Increased
217
Reduced
138
Closed
28

Top Buys

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$57.9M
2
ANET icon
Arista Networks
ANET
+$42.9M
3
VLO icon
Valero Energy
VLO
+$39.9M
4
RNG icon
RingCentral
RNG
+$39.5M
5
MSFT icon
Microsoft
MSFT
+$39M

Sector Composition

Rank Sector Weight
1 Technology 20.91%
2 Healthcare 17.53%
3 Industrials 15.6%
4 Consumer Discretionary 13.47%
5 Financials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
S
226
DELISTED
Sprint Corporation
S
$22.1M 0.16%
3,908,249
-9,500
-0.2% -$58.8K
ABT icon
227
Abbott
ABT
$183B
$22M 0.16%
275,523
+33,278
+14% +$2.48M
MANH icon
228
Manhattan Associates
MANH
$11.2B
$21.9M 0.16%
579,292
-206,534
-26% -$10.6M
LNC icon
229
Lincoln National
LNC
$8.73B
$21.7M 0.15%
369,675
+181,175
+96% +$10.7M
AIMT
230
DELISTED
Aimmune Therapeutics
AIMT
$21.6M 0.15%
964,906
JAZZ icon
231
Jazz Pharmaceuticals
JAZZ
$15.9B
$21.6M 0.15%
150,750
-152,450
-50% -$19.9M
CCI icon
232
Crown Castle
CCI
$33.3B
$21.4M 0.15%
166,840
+20,149
+14% +$2.36M
AMN icon
233
AMN Healthcare
AMN
$1.3B
$21.2M 0.15%
450,500
+348,323
+341% +$19.3M
BWXT icon
234
BWX Technologies
BWXT
$15.5B
$21.1M 0.15%
425,725
+9,275
+2% +$439K
NUVA
235
DELISTED
NuVasive, Inc.
NUVA
$21.1M 0.15%
371,614
-367,425
-50% -$19.5M
HR
236
DELISTED
Healthcare Realty Trust Incorporated
HR
$20.9M 0.15%
651,150
-174,975
-21% -$5.49M
EVH icon
237
Evolent Health
EVH
$348M
$20.5M 0.15%
1,633,453
EHC icon
238
Encompass Health
EHC
$11B
$20.4M 0.14%
438,403
JBLU icon
239
JetBlue
JBLU
$2.28B
$20.3M 0.14%
1,242,200
+32,825
+3% +$562K
FHN icon
240
First Horizon
FHN
$12.2B
$20.3M 0.14%
1,450,425
+193,700
+15% +$2.86M
MO icon
241
Altria Group
MO
$114B
$20M 0.14%
348,030
+42,038
+14% +$2.15M
PTEN icon
242
Patterson-UTI
PTEN
$3.98B
$19.9M 0.14%
1,417,750
+810,625
+134% +$10.6M
POR icon
243
Portland General Electric
POR
$5.8B
$19.7M 0.14%
380,200
+103,150
+37% +$5.03M
SUPN icon
244
Supernus Pharmaceuticals
SUPN
$2.59B
$19.7M 0.14%
562,360
-60,100
-10% -$2.24M
CCL icon
245
Carnival Corporation Ltd
CCL
$38.1B
$19.3M 0.14%
380,805
+45,996
+14% +$2.55M
WFC icon
246
Wells Fargo
WFC
$261B
$19.3M 0.14%
399,627
+48,270
+14% +$2.37M
MOH icon
247
Molina Healthcare
MOH
$10.2B
$19.3M 0.14%
135,833
-104,625
-44% -$14.1M
TTE icon
248
TotalEnergies
TTE
$195B
$19.3M 0.14%
346,170
+41,813
+14% +$2.33M
PEP icon
249
PepsiCo
PEP
$190B
$19.2M 0.14%
156,560
+18,908
+14% +$2.15M
MDT icon
250
Medtronic
MDT
$109B
$19.1M 0.14%
209,492
+25,303
+14% +$2.26M

Similar funds

Carillon Tower Advisers's Q1 2019 Portfolio in Review

As of Q1 2019, Carillon Tower Advisers held 488 positions worth $14.1B, up 20% from $11.8B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Carillon Tower Advisers's Q1 2019 filing shows 31 new, 217 increased, 138 reduced and 28 closed positions. Its largest new stake was Valero Energy: 483,092 shares worth $41M. The largest sale was Centene, an estimated $88.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Carillon Tower Advisers's largest Q1 2019 buy was Valero Energy: 483,092 shares worth $41M.
  • Carillon Tower Advisers added most to ServiceNow in Q1 2019, an estimated $57.9M increase.
  • Carillon Tower Advisers's biggest Q1 2019 reduction was Centene, cutting an estimated $88.3M.
  • Carillon Tower Advisers fully exited WABCO HOLDINGS INC. in Q1 2019, selling an estimated $41.5M.
  • Carillon Tower Advisers's ten largest holdings make up 9.8% of its $14.1B portfolio in Q1 2019.
  • Carillon Tower Advisers opened 31 new positions and closed 28 in Q1 2019.
  • Carillon Tower Advisers's portfolio value rose 20% quarter-over-quarter to $14.1B.

Based on Carillon Tower Advisers's 13F filing for Q1 2019, filed 3 May 2019.